{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:45:14Z","timestamp":1784306714605,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.euroneuro.2017.06.014","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T16:01:19Z","timestamp":1499356879000},"page":"854-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effect of the muscarinic M 1 receptor antagonist biperiden on cognition in medication free subjects with psychosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Claudia","family":"Vingerhoets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geor","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelske","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald J.N.","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese A.M.J.","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2017.06.014_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archpsyc.1992.01820080023004","article-title":"The Comprehensive Assessment of Symptoms and History (CASH)","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neubiorev.2010.01.012","article-title":"Assessing cognitive function in clinical trials of schizophrenia","volume":"34","author":"Barnett","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(25)11335-9","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00131746-200511000-00003","article-title":"Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use","volume":"11","author":"Burton","year":"2005","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1022844517200","article-title":"Use of M1\u2013M5 Muscarinic Receptor Knockout Mice as Novel Tools to Delineate the Physiological Roles of the Muscarinic Cholinergic System","volume":"28","author":"Bymaster","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neubiorev.2015.05.011","article-title":"The muscarinic system, cognition and schizophrenia","volume":"55","author":"Carruthers","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2005.02.020","article-title":"A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients","volume":"77","author":"Chen","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0006-3223(00)00918-5","article-title":"Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation","volume":"48","author":"Crook","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1176\/appi.ajp.158.6.918","article-title":"Low Muscarinic receptor binding in prefrontal cortex from subjects with Schizophrenia: and the Effects of Neuroleptic Drug Treatment","volume":"158","author":"Crook","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib10","first-page":"54","article-title":"The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia","volume":"1","author":"Dean","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.mp.4001199","article-title":"Decreased muscarinic 1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"7","author":"Dean","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/2045125314553611","article-title":"Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia","volume":"4","author":"Desmarais","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2362.1998.00393.x","article-title":"Scopolamine model of dementia: electroencephalogram findings and cognitive performance","volume":"28","author":"Ebert","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbr.2005.11.022","article-title":"Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts","volume":"168","author":"Fadda","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-004-1794-x","article-title":"Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists","volume":"174","author":"Friedman","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S1461145712000028","article-title":"Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia","volume":"16","author":"Gibbons","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1037\/0003-066X.60.3.229","article-title":"The primacy of cognition in schizophrenia","volume":"60","author":"Heinrichs","year":"2005","journal-title":"Am. Psychol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/FBP.0b013e32832c70f5","article-title":"Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity","volume":"20","author":"Hodges","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF00556903","article-title":"Biperiden effects and plasma levels in volunteers","volume":"27","author":"Hollmann","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib21","first-page":"261","article-title":"Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain","volume":"69","author":"Katayama","year":"1990","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-011-2171-1","article-title":"A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment","volume":"215","author":"Klinkenberg","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/S1461145711001647","article-title":"Human electrophysiological correlates of learned irrelevance: effects of the muscarinic M1 antagonist biperiden","volume":"15","author":"Klinkenberg","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.eurpsy.2006.11.004","article-title":"Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB","volume":"22","author":"Levaux","year":"2007","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0024-3205(93)90300-R","article-title":"Immunological localization of m1\u2013m5 muscarinic acetylcholine receptors in peripheral tissues and brain","volume":"52","author":"Levey","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/014107680009300903","article-title":"Anticholinergic side-effects of drugs in elderly people","volume":"93","author":"Mintzer","year":"2000","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.161.1.116","article-title":"Association of anticholinergic load with impairment of complex attention and memory in schizophrenia","volume":"161","author":"Minzenberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","article-title":"Identification of separable cognitive factors in schizophrenia","volume":"72","author":"Nuechterlein","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.schres.2005.03.001","article-title":"Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program","volume":"77","author":"Prouteau","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.mp.4001924","article-title":"Towards a muscarinic hypothesis of schizophrenia","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13803390500360372","article-title":"Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders","volume":"28","author":"Reichenberg","year":"2006","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib36","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00213-014-3822-9","article-title":"Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram","volume":"232","author":"Sambeth","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib37","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.lfs.2005.06.038","article-title":"No change in cortical muscarinic M2, M3 receptors or [35S]GTP\u03b3S binding in schizophrenia","volume":"78","author":"Scarr","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2017.06.014_bib38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/mp.2008.28","article-title":"Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia","volume":"14","author":"Scarr","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib40","doi-asserted-by":"crossref","first-page":"e1.28-e1","DOI":"10.1136\/jnnp-2012-303538.34","article-title":"P17\u2005Acetylcholinesterase inhibitors for schizophrenia","volume":"83","author":"Singh","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/13546805.2012.731390","article-title":"To cut a short test even shorter: reliability and validity of a brief assessment of intellectual ability in schizophrenia--a control-case family study","volume":"18","author":"Velthorst","year":"2013","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00213-014-3794-9","article-title":"Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers","volume":"232","author":"Veselinovi\u0107","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2017.06.014_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fpsyt.2013.00157","article-title":"Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: what\u05f3s the evidence?","volume":"4","author":"Vingerhoets","year":"2013","journal-title":"Front. psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17302912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17302912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T12:39:44Z","timestamp":1750509584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X17302912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0924977X17302912"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.014","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of the muscarinic M1 receptor antagonist biperiden on cognition in medication free subjects with psychosis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}